These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34193068)

  • 1. Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis.
    Nukui T; Matsui A; Niimi H; Sugimoto T; Hayashi T; Dougu N; Konishi H; Yamamoto M; Anada R; Matsuda N; Kitajima I; Nakatsuji Y
    BMC Neurol; 2021 Jun; 21(1):255. PubMed ID: 34193068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kasai T; Tokuda T; Ishigami N; Sasayama H; Foulds P; Mitchell DJ; Mann DM; Allsop D; Nakagawa M
    Acta Neuropathol; 2009 Jan; 117(1):55-62. PubMed ID: 18989684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Liu J; Gao L; Zang D
    PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
    Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
    Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.
    Nakane S; Fujita K; Azuma S; Urushihara R; Kamada M; Harada M; Izumi Y; Kaji R
    Clin Neurol Neurosurg; 2018 Sep; 172():162-168. PubMed ID: 30016754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
    Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of MIP-1α in CSF and serum of ALS.
    Yang X; Gao L; Wu X; Zhang Y; Zang D
    Acta Neurol Scand; 2016 Aug; 134(2):94-100. PubMed ID: 26427609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment.
    Wormser U; Mandrioli J; Vinceti M; Fini N; Sintov A; Brodsky B; Proskura E; Finkelstein Y
    J Neuroinflammation; 2016 Jun; 13(1):131. PubMed ID: 27245439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes.
    Zhou J; Zeng Q; Liao Q; Niu Q; Gu W; Su D; Li S; Xiao B; Bi F
    Ann Clin Transl Neurol; 2023 Aug; 10(8):1467-1480. PubMed ID: 37350306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the levels of CSF and serum factors in ALS.
    Guo J; Yang X; Gao L; Zang D
    Brain Behav; 2017 Mar; 7(3):e00637. PubMed ID: 28293476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Oxidation-Reduction Potential of Cerebrospinal Fluid Be a Monitoring Biomarker in Amyotrophic Lateral Sclerosis?
    Opačić M; Stević Z; Baščarević V; Živić M; Spasić M; Spasojević I
    Antioxid Redox Signal; 2018 Jun; 28(17):1570-1575. PubMed ID: 29113448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.